Cargando…

Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model

BACKGROUND: A strategy for accelerating liver regeneration after hepatectomy would offer great benefits in preventing postoperative liver failure and improving surgical outcomes. Transforming growth factor (TGF) β is a potent inhibitor of hepatocyte proliferation. Recently, thrombospondin (TSP) 1 ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuroki, H, Hayashi, H, Nakagawa, S, Sakamoto, K, Higashi, T, Nitta, H, Hashimoto, D, Chikamoto, A, Beppu, T, Baba, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654236/
https://www.ncbi.nlm.nih.gov/pubmed/25866938
http://dx.doi.org/10.1002/bjs.9765
_version_ 1782402026880106496
author Kuroki, H
Hayashi, H
Nakagawa, S
Sakamoto, K
Higashi, T
Nitta, H
Hashimoto, D
Chikamoto, A
Beppu, T
Baba, H
author_facet Kuroki, H
Hayashi, H
Nakagawa, S
Sakamoto, K
Higashi, T
Nitta, H
Hashimoto, D
Chikamoto, A
Beppu, T
Baba, H
author_sort Kuroki, H
collection PubMed
description BACKGROUND: A strategy for accelerating liver regeneration after hepatectomy would offer great benefits in preventing postoperative liver failure and improving surgical outcomes. Transforming growth factor (TGF) β is a potent inhibitor of hepatocyte proliferation. Recently, thrombospondin (TSP) 1 has been identified as a negative regulator of liver regeneration by activation of local TGF-β signals. This study aimed to clarify whether the LSKL (leucine–serine–lysine–leucine) peptide, which inhibits TSP-1-mediated TGF-β activation, promotes liver regeneration after hepatectomy in mice. METHODS: Mice were operated on with a 70 per cent hepatectomy or sham procedure. Operated mice received either LSKL peptide or normal saline intraperitoneally at abdominal closure and 6 h after hepatectomy. Perioperative plasma TSP-1 levels were measured by enzyme-linked immunosorbent assay in patients undergoing hepatectomy. RESULTS: Administration of LSKL peptide attenuated Smad2 phosphorylation at 6 h. S-phase entry of hepatocytes was accelerated at 24 and 48 h by LSKL peptide, which resulted in faster recovery of the residual liver and bodyweight. Haematoxylin and eosin tissue staining and blood biochemical examinations revealed no significant adverse effects following the two LSKL peptide administrations. In the clinical setting, plasma TSP-1 levels were lowest on the first day after hepatectomy. However, plasma TSP-1 levels at this stage were significantly higher in patients with subsequent liver dysfunction compared with levels in those without liver dysfunction following hepatectomy. CONCLUSION: Only two doses of LSKL peptide during the early period after hepatectomy can promote liver regeneration. The transient inhibition of TSP-1/TGF-β signal activation using LSKL peptide soon after hepatectomy may be a promising strategy to promote subsequent liver regeneration.
format Online
Article
Text
id pubmed-4654236
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-46542362015-11-27 Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model Kuroki, H Hayashi, H Nakagawa, S Sakamoto, K Higashi, T Nitta, H Hashimoto, D Chikamoto, A Beppu, T Baba, H Br J Surg Original Articles BACKGROUND: A strategy for accelerating liver regeneration after hepatectomy would offer great benefits in preventing postoperative liver failure and improving surgical outcomes. Transforming growth factor (TGF) β is a potent inhibitor of hepatocyte proliferation. Recently, thrombospondin (TSP) 1 has been identified as a negative regulator of liver regeneration by activation of local TGF-β signals. This study aimed to clarify whether the LSKL (leucine–serine–lysine–leucine) peptide, which inhibits TSP-1-mediated TGF-β activation, promotes liver regeneration after hepatectomy in mice. METHODS: Mice were operated on with a 70 per cent hepatectomy or sham procedure. Operated mice received either LSKL peptide or normal saline intraperitoneally at abdominal closure and 6 h after hepatectomy. Perioperative plasma TSP-1 levels were measured by enzyme-linked immunosorbent assay in patients undergoing hepatectomy. RESULTS: Administration of LSKL peptide attenuated Smad2 phosphorylation at 6 h. S-phase entry of hepatocytes was accelerated at 24 and 48 h by LSKL peptide, which resulted in faster recovery of the residual liver and bodyweight. Haematoxylin and eosin tissue staining and blood biochemical examinations revealed no significant adverse effects following the two LSKL peptide administrations. In the clinical setting, plasma TSP-1 levels were lowest on the first day after hepatectomy. However, plasma TSP-1 levels at this stage were significantly higher in patients with subsequent liver dysfunction compared with levels in those without liver dysfunction following hepatectomy. CONCLUSION: Only two doses of LSKL peptide during the early period after hepatectomy can promote liver regeneration. The transient inhibition of TSP-1/TGF-β signal activation using LSKL peptide soon after hepatectomy may be a promising strategy to promote subsequent liver regeneration. John Wiley & Sons, Ltd 2015-06 2015-04-13 /pmc/articles/PMC4654236/ /pubmed/25866938 http://dx.doi.org/10.1002/bjs.9765 Text en © 2015 The Authors. BJS published by John Wiley & Sons Ltd on behalf of BJS Society Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Kuroki, H
Hayashi, H
Nakagawa, S
Sakamoto, K
Higashi, T
Nitta, H
Hashimoto, D
Chikamoto, A
Beppu, T
Baba, H
Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model
title Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model
title_full Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model
title_fullStr Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model
title_full_unstemmed Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model
title_short Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model
title_sort effect of lskl peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654236/
https://www.ncbi.nlm.nih.gov/pubmed/25866938
http://dx.doi.org/10.1002/bjs.9765
work_keys_str_mv AT kurokih effectoflsklpeptideonthrombospondin1mediatedtransforminggrowthfactorbsignalactivationandliverregenerationafterhepatectomyinanexperimentalmodel
AT hayashih effectoflsklpeptideonthrombospondin1mediatedtransforminggrowthfactorbsignalactivationandliverregenerationafterhepatectomyinanexperimentalmodel
AT nakagawas effectoflsklpeptideonthrombospondin1mediatedtransforminggrowthfactorbsignalactivationandliverregenerationafterhepatectomyinanexperimentalmodel
AT sakamotok effectoflsklpeptideonthrombospondin1mediatedtransforminggrowthfactorbsignalactivationandliverregenerationafterhepatectomyinanexperimentalmodel
AT higashit effectoflsklpeptideonthrombospondin1mediatedtransforminggrowthfactorbsignalactivationandliverregenerationafterhepatectomyinanexperimentalmodel
AT nittah effectoflsklpeptideonthrombospondin1mediatedtransforminggrowthfactorbsignalactivationandliverregenerationafterhepatectomyinanexperimentalmodel
AT hashimotod effectoflsklpeptideonthrombospondin1mediatedtransforminggrowthfactorbsignalactivationandliverregenerationafterhepatectomyinanexperimentalmodel
AT chikamotoa effectoflsklpeptideonthrombospondin1mediatedtransforminggrowthfactorbsignalactivationandliverregenerationafterhepatectomyinanexperimentalmodel
AT bepput effectoflsklpeptideonthrombospondin1mediatedtransforminggrowthfactorbsignalactivationandliverregenerationafterhepatectomyinanexperimentalmodel
AT babah effectoflsklpeptideonthrombospondin1mediatedtransforminggrowthfactorbsignalactivationandliverregenerationafterhepatectomyinanexperimentalmodel